Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
  5. 4 Other acquisition Director acquired 11,068 shares (other)
  6. 4 Exercise or conversion Director acquired 42,337 shares (option exercise)
  7. 4 Shares withheld for taxes Chief Medical Officer gave up 6,597 shares (to pay taxes)
  8. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 5,461 shares (to pay taxes)
  9. 4 Shares withheld for taxes CHIEF LEGAL OFFICER gave up 5,211 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes President, CEO gave up 19,420 shares (to pay taxes)
  18. 4 Open-market buy Director bought 85,098 shares at an average $12.92 ($1,099,642)
  19. 4 Planned sale Director sold 10,000 shares at $25.00 ($250,000)
  20. 4 Planned sale Chief Medical Officer sold 1,500 shares at $38.67 ($58,005)

Page 4 of 15 · 298 filings